StemCore Laboratories is a high-throughput genomics facility within the Ottawa Health Research Institute (OHRI). StemCore Laboratories is developing a world-class infrastructure for genomics, bioinformatics, and proteomics, and is capable of facilitating large-scale scientific research and biotechnology projects. Technologies provided at StemCore Laboratories include DNA Sequencing, Fluorescence Activated Cell Sorting, Affymetrix GeneChip, Agilent Bioanalyzer, Next Generation Sequencing.

Stemcore Laboratories seeks out projects that are challenging, cutting-edge, extend the boundaries of biological knowledge, and will positively impact the state of human health. Please visit the website or contact StemCore for more information about accessing our services.

At StemCore we believe in a revolutionary concept; that stem cell dysfunction lies at the very centre of today’s most devastating illnesses such as cancer, type I diabetes, cardiac, Parkinson’s, Muscular Dystrophy, and Alzheimer’s. Furthermore, the use of stem cells for regenerative therapy presents the opportunity to transform medical practice and pharmaceutical intervention for these diseases. In order to harness the full potential of stem cells however, basic research is required to understand the mechanisms whereby the two hallmark features of stem cells, self-renewal and differentiation, are accomplished. To that end, StemCore has built an integrated compendium of core technology platforms in order to isolate and characterize stem cells and thereby to elucidate the underlying mechanisms which regulate stem cell function, human development, and health and disease.